NAKA
Nakamoto Inc.
Company overview
- Market capitalization
- $173.94M
- Employees
- 33
- Latest publication
- 2026-09-29
About Nakamoto Inc.
Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies. It offers commercial and financial infrastructure for the capital markets. The company was formerly known as Kindly MD, Inc. and change its name to Nakamoto Inc. in January 2026. Nakamoto Inc. was incorporated in 2019 and is based in Nashville, Tennessee.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q4 20242024-12-31 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 25,451,000USD | 388,209USD | 408,527USD | 603,887USD | 829,029USD | 759,447USD | 869,268USD | 979,538USD |
| Selling General Administrative | 4,697,000USD | 10,781,324USD | 2,777,770USD | 1,183,060USD | 1,033,511USD | 195,100USD | 357,369USD | 1,529,513USD |
| General And Administrative Expenses | 4,697,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 184,948,000USD | 10,791,716USD | 2,792,466USD | 963,307USD | 300,286USD | 195,100USD | 344,367USD | 419,954USD |
| Operating Income | -149,079,000USD | -10,405,522USD | -2,391,491USD | -1,022,632USD | -237,127USD | -302,129USD | -503,403USD | -609,483USD |
| Total Other Income Expense Net | -3,544,000USD | -75,630,286USD | -22,296USD | 21,111USD | -45,199USD | -22,799USD | -11,743USD | 13,075USD |
| Interest Expense | 4,016,000USD | 0USD | 3,668USD | 8,100USD | 57,239USD | 55,844USD | 12,550USD | 8,194USD |
| Net Interest Income | -4,016,000USD | 0USD | -3,668USD | -8,100USD | -57,239USD | — | — | — |
| Income Before Tax | -152,623,000USD | -86,035,808USD | -2,413,787USD | -1,001,521USD | -282,326USD | -324,928USD | -515,146USD | -596,408USD |
| Income Tax Expense | -21,424,000USD | — | — | — | — | 2USD | -4USD | 3USD |
| Discontinued Operations | -1,798,000USD | — | — | — | — | — | — | — |
| Net Income | -132,997,000USD | -86,035,808USD | -2,413,787USD | -1,001,521USD | -282,326USD | -324,928USD | -515,146USD | -596,408USD |
| Cost Of Revenue | — | 2,015USD | 7,552USD | 663,213USD | 765,870USD | 866,476USD | 1,028,304USD | 1,169,067USD |
| Gross Profit | — | 386,194USD | 400,975USD | -59,326USD | 63,159USD | -107,029USD | -159,036USD | -189,529USD |
| Research Development | — | 0USD | 4USD | 377,731USD | 35,417USD | 2,500USD | — | — |
| Tax Provision | — | 0USD | 0USD | 0USD | 0USD | — | — | — |
| Net Income From Continuing Ops | — | -86,035,808USD | -2,413,787USD | -1,001,521USD | -282,326USD | — | — | — |
| Ebit | — | -86,035,808USD | -2,410,119USD | -1,022,632USD | -237,127USD | -302,129USD | -503,403USD | -609,483USD |
| Ebitda | — | -85,370,518USD | -2,299,427USD | -953,737USD | -186,967USD | -228,991USD | -477,399USD | -553,936USD |
| Depreciation And Amortization | — | 665,290USD | 110,692USD | 68,895USD | 50,160USD | 73,138USD | 26,004USD | 55,547USD |
| Reconciled Depreciation | — | 665,290USD | 51,876USD | 68,895USD | 50,160USD | — | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | 13,000USD | — |
| Unclassified Operating Expenses | — | — | — | — | — | — | — | -1,109,559USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|
| Total Revenue | 3,768,598USD | 3,787,077USD | 2,504,319USD |
| Cost Of Revenue | 226,166USD | 152,385USD | 1,589,397USD |
| Gross Profit | 3,542,432USD | 3,634,692USD | 914,922USD |
| Research Development | 2,500USD | — | — |
| Selling General Administrative | 5,054,515USD | 6,274,660USD | 2,355,855USD |
| Total Operating Expenses | 5,162,652USD | 6,328,105USD | 853,582USD |
| Operating Income | -1,620,220USD | -2,693,413USD | 61,340USD |
| Interest Expense | 55,844USD | 0USD | — |
| Net Interest Income | -55,844USD | 0USD | — |
| Income Before Tax | -1,617,461USD | -2,540,593USD | 149,336USD |
| Tax Provision | 0USD | 0USD | 0USD |
| Net Income | -1,617,461USD | -2,540,593USD | 149,336USD |
| Net Income From Continuing Ops | -1,617,461USD | -2,540,593USD | 149,336USD |
| Ebit | -1,561,617USD | -2,540,593USD | 61,340USD |
| Ebitda | -1,358,394USD | -2,418,588USD | 124,737USD |
| Depreciation And Amortization | 203,223USD | 122,005USD | 63,397USD |
| Reconciled Depreciation | 203,223USD | 122,005USD | 63,398USD |
| Total Other Income Expense Net | 2,759USD | 152,820USD | 87,996USD |
| Income Tax Expense | — | 5USD | 3USD |
| Unclassified Operating Expenses | — | — | -1,502,273USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 422,514,000USD | 620,761,000USD | 730,607,754USD | 692,421,574USD | 9,890,282USD | 2,563,591USD | 3,677,992USD | 4,324,162USD |
| Cash And Equivalents | 19,072,000USD | — | — | — | — | — | — | — |
| Long Term Investments | 17,533,000USD | 16,888,000USD | 35,697,320USD | 45,956,627USD | — | — | 0USD | — |
| Total Current Assets | 27,452,000USD | 63,419,000USD | 223,817,232USD | 27,051,797USD | 6,372,254USD | 1,294,619USD | 2,505,652USD | 3,941,333USD |
| Other Current Assets | 3,821,000USD | 22,238,000USD | 201,231,164USD | 2,866,714USD | 339,100USD | 138,836USD | 190,878USD | 250,316USD |
| Other Non Current Assets | 2,295,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 186,102,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 179,474,000USD | 251,699,000USD | 215,985,162USD | 214,459,522USD | 490,416USD | 562,409USD | 606,050USD | 725,867USD |
| Other Current Liabilities | 106,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 351,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 236,412,000USD | 367,074,000USD | 514,256,626USD | 477,562,085USD | 8,966,888USD | 1,529,050USD | 2,568,310USD | 3,484,055USD |
| Total Equity Including Noncontrolling Interest | 236,412,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 3,448,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 3,778,000USD | — | — | — | — | — | — | — |
| Goodwill | 16,391,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 97,129,000USD | 446,762,000USD | 470,558,903USD | 3,009,281USD | 2,870,427USD | 561,786USD | 388,338USD | — |
| Accounts Payable | 10,974,000USD | 13,093,000USD | 5,859,341USD | 5,846,215USD | 364,201USD | 366,348USD | 323,725USD | 431,516USD |
| Common Stock | 18,000USD | 690,000USD | 439,950USD | 427,152USD | 7,576USD | 6,050USD | 6,050USD | 5,977USD |
| Retained Earnings | -431,778,000USD | -298,781,000USD | -60,004,624USD | -97,263,307USD | -11,227,499USD | -8,813,712USD | -7,775,701USD | -6,774,180USD |
| Accumulated Other Comprehensive Income | -222,000USD | -131,000USD | — | — | — | — | — | — |
| Total Liab | — | 253,687,000USD | 216,351,128USD | 214,859,489USD | 923,394USD | 1,034,541USD | 1,109,682USD | 840,107USD |
| Other Current Liab | — | 5,748,000USD | 568,207USD | 5,469,000USD | 175USD | 366,348USD | 2,275USD | 2,750USD |
| Capital Stock | — | 690,000USD | 439,950USD | 427,152USD | 7,576USD | 6,050USD | 6,050USD | 5,977USD |
| Good Will | — | 93,506,000USD | — | — | — | — | — | — |
| Cash | — | 35,300,000USD | 22,583,253USD | 24,185,083USD | 6,024,604USD | 1,140,574USD | 2,273,624USD | 3,642,944USD |
| Cash And Short Term Investments | — | 35,300,000USD | 22,583,253USD | 24,185,083USD | 6,024,604USD | 1,140,574USD | 2,273,624USD | 3,642,944USD |
| Current Deferred Revenue | — | 23,118,000USD | — | — | 175USD | 1,800USD | 2,275USD | 2,750USD |
| Net Debt | — | 174,440,000USD | 187,340,327USD | 179,359,191USD | -5,465,586USD | -474,181USD | -1,489,943USD | -3,237,103USD |
| Short Term Debt | — | 209,740,000USD | 209,557,614USD | 203,144,307USD | 126,040USD | 194,261USD | 280,050USD | 291,601USD |
| Short Long Term Debt | — | 209,740,000USD | 209,557,614USD | 203,017,500USD | — | 60,968USD | 139,277USD | 188,599USD |
| Short Long Term Debt Total | — | 209,740,000USD | 209,923,580USD | 203,544,274USD | 559,018USD | 666,393USD | 783,681USD | 405,841USD |
| Net Receivables | — | 5,881,000USD | 2,815USD | — | 7,472USD | 13,614USD | 36,850USD | 45,323USD |
| Common Stock Shares Outstanding | — | 15,911,800shares | 11,364,692shares | 11,364,692shares | 6,817,584shares | 6,105,882shares | 6,029,648shares | 5,977,476shares |
| Non Current Assets Total | — | 557,342,000USD | 506,790,522USD | 665,369,777USD | 3,518,028USD | 1,268,972USD | 1,172,340USD | 382,829USD |
| Non Current Liabilities Total | — | 1,988,000USD | 365,966USD | 399,967USD | 432,978USD | 472,132USD | 503,632USD | 114,240USD |
| Non Current Liabilities Other | — | 366,000USD | — | — | — | — | 503,632USD | — |
| Non Currrent Assets Other | — | 186,000USD | 534,299USD | 615,816,958USD | 18,121USD | 19,396USD | 19,396USD | 11,276USD |
| Net Working Capital | — | -188,280,000USD | 7,832,070USD | -187,407,725USD | 5,881,838USD | 732,210USD | 1,899,602USD | 3,215,466USD |
| Unclassified Current Liabilities | — | -209,740,000USD | -209,557,614USD | -203,017,500USD | — | — | — | — |
| Unclassified Non Current Liabilities | — | 1,622,000USD | — | — | — | — | — | — |
| Unclassified Equity | — | 664,606,000USD | 573,381,350USD | 573,971,088USD | 20,179,235USD | 10,330,662USD | 10,331,911USD | 10,246,281USD |
| Inventory | — | — | 0USD | — | 1,078USD | 1,595USD | 4,300USD | 2,750USD |
| Property Plant Equipment Net | — | — | — | 586,911USD | 629,480USD | 687,790USD | 764,606USD | 371,553USD |
| Property Plant Equipment Gross | — | — | — | 784,323USD | 816,501USD | 886,137USD | 945,152USD | 611,774USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Assets | 730,607,754USD | 3,677,992USD | 1,099,202USD | 946,998USD | 447,643USD |
| Intangible Assets | 470,558,903USD | 388,338USD | — | — | — |
| Other Current Assets | 201,231,164USD | 190,878USD | 225USD | 60,958USD | 101,511USD |
| Total Liab | 216,351,128USD | 1,109,682USD | 1,207,614USD | 565,984USD | 174,557USD |
| Total Stockholder Equity | 514,256,626USD | 2,568,310USD | -108,412USD | 381,014USD | 273,086USD |
| Other Current Liab | 568,207USD | 323,725USD | 238,000USD | 166,258USD | -53,544USD |
| Common Stock | 439,950USD | 6,050USD | 4,618USD | 4,434USD | 273,086USD |
| Capital Stock | 439,950USD | 6,050USD | 4,618USD | 4,434USD | 0USD |
| Retained Earnings | -60,004,624USD | -7,775,701USD | -4,158,054USD | -2,540,593USD | — |
| Cash | 22,583,253USD | 2,273,624USD | 525,500USD | 186,918USD | 94,689USD |
| Cash And Short Term Investments | 22,583,253USD | 2,273,624USD | 525,500USD | 186,918USD | 94,689USD |
| Total Current Assets | 223,817,232USD | 2,505,652USD | 616,928USD | 309,567USD | 269,444USD |
| Total Current Liabilities | 215,985,162USD | 606,050USD | 814,448USD | 327,899USD | 118,290USD |
| Net Debt | 187,340,327USD | -1,489,942USD | 110,879USD | 204,208USD | 15,122USD |
| Short Term Debt | 209,557,614USD | 280,050USD | 243,213USD | 153,041USD | 53,544USD |
| Short Long Term Debt | 209,557,614USD | 139,277USD | 148,517USD | 92,545USD | — |
| Short Long Term Debt Total | 209,923,580USD | 783,682USD | 636,379USD | 391,126USD | 109,811USD |
| Long Term Investments | 35,697,320USD | 0USD | — | — | — |
| Net Receivables | 2,815USD | 36,850USD | 28,000USD | 12,123USD | 13,474USD |
| Inventory | 0USD | 4,300USD | 63,202USD | 49,568USD | 59,770USD |
| Accounts Payable | 5,859,341USD | 323,725USD | 329,810USD | 166,258USD | 47,496USD |
| Common Stock Shares Outstanding | 11,364,692shares | 5,391,433shares | 5,890,525shares | 5,890,525shares | 5,971,333shares |
| Non Current Assets Total | 506,790,522USD | 1,172,340USD | 482,274USD | 637,431USD | 178,199USD |
| Non Current Liabilities Total | 365,966USD | 503,632USD | 393,166USD | 238,085USD | 56,266USD |
| Non Currrent Assets Other | 534,299USD | 19,426USD | 11,276USD | 14,505USD | 6,630USD |
| Net Working Capital | 7,832,070USD | 1,899,602USD | -197,520USD | -18,332USD | 151,154USD |
| Unclassified Current Liabilities | -209,557,614USD | — | — | — | — |
| Unclassified Equity | 573,381,350USD | 10,331,911USD | 4,040,406USD | 2,912,739USD | — |
| Current Deferred Revenue | — | 2,275USD | 3,425USD | 8,600USD | 17,250USD |
| Property Plant Equipment Net | — | 764,576USD | 470,998USD | 622,926USD | 171,569USD |
| Property Plant Equipment Gross | — | 945,152USD | 635,009USD | 681,300USD | 176,498USD |
| Non Current Liabilities Other | — | 503,632USD | — | — | — |
| Long Term Debt | — | — | 228,871USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 3,529,000USD |
| Stock Based Compensation | 3,839,000USD |
| Change To Liabilities | -9,895,000USD |
| Change In Working Capital | -4,058,000USD |
| Operating Cash Flow | -26,538,000USD |
| Capital Expenditures | -500,000USD |
| Unclassified Investing Cash Flow | 34,806,000USD |
| Investing Cash Flow | 34,306,000USD |
| Net Common Stock Issuance | -561,000USD |
| Unclassified Financing Cash Flow | -9,205,000USD |
| Financing Cash Flow | -9,766,000USD |
| Change In Cash | -1,998,000USD |
| End Cash Flow | 19,072,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -238,776,000USD | 37,258,683USD | -86,035,808USD | -2,413,798USD | -1,038,000USD | -1,001,521USD | -1,014,146USD | -1,319,653USD |
| Depreciation | 1,115,000USD | -551,989USD | 665,290USD | 110,692USD | 18,000USD | 68,895USD | 49,273USD | 52,003USD |
| Stock Based Compensation | 1,607,000USD | 206,261USD | 1,531,552USD | 612,110USD | 9,000USD | 28,301USD | 117,494USD | 7,884USD |
| Other Non Cash Items | 219,497,000USD | -44,779,515USD | 74,863,872USD | 16,355USD | 70,000USD | 147,513USD | 127,100USD | 295,803USD |
| Change In Working Capital | -6,728,000USD | 299,029USD | -4,192,572USD | -236,661USD | 76,000USD | -116,417USD | -207,612USD | 58,310USD |
| Total Cash From Operating Activities | -23,285,000USD | -7,567,531USD | -13,167,666USD | -1,911,302USD | -865,000USD | -901,530USD | -1,045,385USD | -913,537USD |
| Capital Expenditures | -23,285,000USD | -1USD | -2,859USD | -58,523USD | -173,000USD | -388,340USD | -2,105USD | -3USD |
| Free Cash Flow | -23,285,000USD | -7,567,532USD | -13,170,525USD | -1,969,825USD | -1,038,000USD | -901,530USD | -1,047,490USD | -913,540USD |
| Investments | 11,140,000USD | 6,276,549USD | -683,779,913USD | -2,347,660USD | -173,448USD | -388,340USD | -2,109USD | 0USD |
| Total Cashflows From Investing Activities | 36,563,000USD | 6,276,548USD | -683,779,913USD | -2,348,108USD | -173,000USD | -388,340USD | -2,109USD | — |
| Net Borrowings | 0USD | 0USD | 191,367,500USD | -73,511USD | -84,962USD | -57,305USD | -49,568USD | — |
| Total Cash From Financing Activities | -561,000USD | -310,847USD | 715,108,058USD | 9,143,390USD | -95,000USD | -79,450USD | -49,568USD | 5,366,160USD |
| Sale Purchase Of Stock | -561,000USD | -310,847USD | 9,557USD | 443USD | -10,000USD | -22,145USD | 0USD | 0USD |
| Change In Cash | 12,717,000USD | -1,601,830USD | 18,160,479USD | 4,883,604USD | -1,133,000USD | -1,369,320USD | -1,097,062USD | 4,452,623USD |
| Begin Period Cash Flow | 22,583,000USD | 24,185,083USD | 6,024,604USD | 1,141,000USD | 2,274,000USD | 3,642,944USD | 4,740,006USD | 287,383USD |
| End Period Cash Flow | 35,300,000USD | 22,583,253USD | 24,185,083USD | 6,024,604USD | 1,141,000USD | 2,273,624USD | 3,642,944USD | 4,740,006USD |
| Other Cashflows From Investing Activities | 16,693,000USD | -15,000,000USD | -683,777,054USD | -2,289,585USD | -173,448USD | -388,338USD | — | 3USD |
| Other Cashflows From Financing Activities | -561,000USD | -724,061,929USD | 114USD | 9,216,420USD | -504USD | -1,331USD | — | -331USD |
| Unclassified Investing Cash Flow | 32,015,000USD | 15,000,000USD | 683,779,913USD | 2,347,660USD | — | — | — | — |
| Change To Account Receivables | — | -14,531USD | 2,743USD | 8,642USD | 11,788USD | -23,637USD | -40,141USD | 2,372USD |
| Change To Inventory | — | -3,783USD | 1,078USD | 517USD | 2,705USD | -1,550USD | 1,075USD | 52,047USD |
| Issuance Of Capital Stock | — | 0USD | 523,740,444USD | — | — | 0USD | 0USD | — |
| Unclassified Financing Cash Flow | — | 724,061,929USD | 523,730,887USD | — | — | — | — | 5,366,491USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Net Income | -52,228,923USD | -3,617,647USD | -1,617,461USD | -2,540,593USD | 149,336USD |
| Depreciation | 241,993USD | 220,331USD | 203,223USD | 122,005USD | 63,397USD |
| Stock Based Compensation | 2,358,923USD | 240,915USD | 414,685USD | 2,216,344USD | 0USD |
| Other Non Cash Items | 30,170,712USD | 384,476USD | 433,702USD | 28,629USD | 1USD |
| Change In Working Capital | -4,054,204USD | -301,966USD | 116,362USD | 33,232USD | -91,293USD |
| Total Cash From Operating Activities | -23,511,499USD | -3,073,891USD | -449,489USD | -140,383USD | 121,441USD |
| Capital Expenditures | -234,383USD | -401,631USD | -14,420USD | -317,388USD | -63,601USD |
| Free Cash Flow | -23,745,882USD | -3,475,522USD | -463,909USD | -457,771USD | 57,840USD |
| Investments | 46,276,659USD | -401,631USD | -14,420USD | -317,388USD | -63,602USD |
| Total Cashflows From Investing Activities | -680,024,473USD | -401,631USD | -14,420USD | -317,388USD | -63,602USD |
| Net Borrowings | 191,209,027USD | -614,859USD | 802,491USD | 150,000USD | -47,341USD |
| Total Cash From Financing Activities | 723,845,601USD | 5,223,646USD | 802,491USD | 550,000USD | -45,341USD |
| Sale Purchase Of Stock | -320,404USD | -22,145USD | 0USD | — | — |
| Issuance Of Capital Stock | 523,740,444USD | 5,860,650USD | 0USD | 400,000USD | 2,000USD |
| Change In Cash | 20,309,629USD | 1,748,124USD | 338,582USD | 92,229USD | 94,689USD |
| Begin Period Cash Flow | 2,273,624USD | 525,500USD | 186,918USD | 94,689USD | 82,191USD |
| End Period Cash Flow | 22,583,253USD | 2,273,624USD | 525,500USD | 186,918USD | 94,689USD |
| Other Cashflows From Investing Activities | -655,022,614USD | -388,338USD | — | — | — |
| Other Cashflows From Financing Activities | 9,216,534USD | — | — | 400,000USD | -47,341USD |
| Unclassified Investing Cash Flow | -71,044,135USD | — | — | — | — |
| Unclassified Financing Cash Flow | 523,740,444USD | 5,860,650USD | — | — | — |
| Change To Account Receivables | — | -40,959USD | -15,878USD | -7,123USD | 401USD |
| Change To Inventory | — | 58,902USD | -13,634USD | 10,202USD | -30,643USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Advisory | 510,000 | USD | 0001493152-26-022777 |
| Q1 2026Quarterly · 2026-03-31 | Product | Asset Management | 209,000 | USD | 0001493152-26-022777 |
| Q1 2026Quarterly · 2026-03-31 | Product | Derivatives | 1,071,000 | USD | 0001493152-26-022777 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care | 479,000 | USD | 0001493152-26-022777 |
| Q1 2026Quarterly · 2026-03-31 | Product | Media | 409,000 | USD | 0001493152-26-022777 |
| FY 2025Yearly · 2025-12-31 | Product | Patient Care Services | 1,811,940 | USD | 0001493152-26-013601 |
| FY 2025Yearly · 2025-12-31 | Product | Product Retail Sales | 1,479 | USD | 0001493152-26-013601 |
| FY 2025Yearly · 2025-12-31 | Product | Service Affiliate Agreements | 7,896 | USD | 0001493152-26-013601 |
| Q3 2025Quarterly · 2025-09-30 | Product | Patient Care Services | 388,041 | USD | 0001493152-25-024260 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product Retail Sales | 168 | USD | 0001493152-25-024260 |
| Q2 2025Quarterly · 2025-06-30 | Product | Patient Care Services | 408,039 | USD | 0001641172-25-022128 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product Retail Sales | 488 | USD | 0001641172-25-022128 |
| Q1 2025Quarterly · 2025-03-31 | Product | Patient Care Services | 570,936 | USD | 0001641172-25-009328 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product Retail Sales | 823 | USD | 0001641172-25-009328 |
| Q1 2025Quarterly · 2025-03-31 | Product | Service Affiliate Agreements | 7,896 | USD | 0001641172-25-009328 |
| FY 2024Yearly · 2024-12-31 | Product | Patient Care Services | 2,616,018 | USD | 0001493152-26-013601 |
| FY 2024Yearly · 2024-12-31 | Product | Product Retail Sales | 71,712 | USD | 0001493152-26-013601 |
| FY 2024Yearly · 2024-12-31 | Product | Service Affiliate Agreements | 32,110 | USD | 0001493152-26-013601 |
| Q3 2024Quarterly · 2024-09-30 | Product | Patient Care Services | 627,144 | USD | 0001493152-25-024260 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product Retail Sales | -1,709 | USD | 0001493152-25-024260 |
| Q3 2024Quarterly · 2024-09-30 | Product | Service Affiliate Agreements | 22,432 | USD | 0001493152-25-024260 |
| Q2 2024Quarterly · 2024-06-30 | Product | Patient Care Services | 608,925 | USD | 0001641172-25-022128 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product Retail Sales | 30,132 | USD | 0001641172-25-022128 |
| Q1 2024Quarterly · 2024-03-31 | Product | Patient Care Services | 785,843 | USD | 0001641172-25-009328 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product Retail Sales | 43,186 | USD | 0001641172-25-009328 |
| Q4 2023Quarterly · 2023-12-31 | Product | Patient Care Services | 718,778 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Product Retail Sales | 40,669 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Product | Patient Care Services | 3,505,283 | USD | 0001641172-25-001314 |
| FY 2023Yearly · 2023-12-31 | Product | Product Retail Sales | 263,315 | USD | 0001641172-25-001314 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.